SCHEMBL7348969

SCHEMBL7348969

Cc1c(Cl)ccc2nc[nH]c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.37
MAPT P10636 3/20 0.36
CSNK2A1 P68400 2/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
MMP12 P39900 1/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ALDH1A1 P00352 1/20 0.33
DAO P14920 1/20 0.33
DYRK1A Q13627 1/20 0.33
CHEK1 O14757 1/20 0.33
PIM1 P11309 1/20 0.33
RPS6KA3 P51812 1/20 0.33
PRKCI P41743 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29503821 0.79 PARP1 (0.39) PARP1MAPTMMP12NPC1TP53
SCHEMBL3156088 0.79 PARP1 (0.39) PARP1MAPTMMP12NPC1TP53
SCHEMBL29805281 0.79 CSNK2A1 (0.39) PARP1MAPTCSNK2A1CSNK2A2CSNK2B
SCHEMBL4535251 0.79 CSNK2A1 (0.39) PARP1MAPTCSNK2A1CSNK2A2CSNK2B
SCHEMBL6581871 0.76 PRKCI (0.41) PARP1MAPTCSNK2A1CSNK2A2CSNK2B
SCHEMBL1798450 0.76 PARP1 (0.37) PARP1MAPTCSNK2A1CSNK2A2CSNK2B
SCHEMBL4908126 0.76 CSNK2A1 (0.37) PARP1MAPTCSNK2A1MMP12NPC1
SCHEMBL23841481 0.76 PARP1 (0.34) PARP1MAPTCSNK2A1MMP12ALDH1A1
SCHEMBL23841441 0.76 ACP1 (0.35) PARP1MAPTCSNK2A1MMP12NPC1
SCHEMBL1374558 0.75 PRKCI (0.44) PARP1MAPTCSNK2A1CSNK2A2CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed